CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > New South Wales Public Health Bulletin   
New South Wales Public Health Bulletin
http://www.health.nsw.gov.au
  Supporting public health practice in New South Wales
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
Content

red arrow Cumulative Indexes
blank image
Cumulative Subject Index Cumulative Author Index

red arrow Connect with CP
blank image
facebook twitter youtube

 

Article << Previous     |     Next >>   Contents Vol 22(12)

Invasive pneumococcal disease in western Sydney, 2002–2010

Kristina L. Flego A C , George Truman A , Vicky Sheppeard A and Robin E. Gilmour B

A Centre for Population Health, Clinical Support Division Western
B Communicable Diseases Branch, NSW Department of Health
C Corresponding author. Email: Kristina.Flego@swahs.health.nsw.gov.au

NSW Public Health Bulletin 22(12) 219-221 http://dx.doi.org/10.1071/NB11012
Published: 22 December 2011


 
 Full Text
 PDF (138 KB)
 Export Citation
 Print
  


References

[1]  Department of Health and Ageing Vaccine Preventable Diseases in Australia, 2005–2007. Commun Dis Intell 2010; 34: .

[2]  Health NSW. Response Protocol for NSW Public Health Units. Pneumococcal Disease (Invasive). September 2004. Available from: http://www.health.nsw.gov.au/factsheets/guideline/pneumo.html (Cited 27 May 2011.)

[3]  Isaacman DJ, Fletcher MA, Fritzell B, Ciuryla V, Shranz J. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7;Prevenar). Vaccine 2007; 25: 2420–7..
CrossRef |

[4]  Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006; 24: 468–75.
CrossRef | CAS |

[5]  Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Changing epidemiology of invasive pneumococcal disease in Canada, 1998–2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 2009; 49: 205–12.
CrossRef |

[6]  Sydney West Immunisation Strategy 2010–13. Parramatta: Centre for Population Health; 2010.

[7]  Dias R, Caniça M. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol 2007; 51: 35–42.
CrossRef | CAS |

[8]  Lynch JP, Zhanel GG. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010; 16: 217–25.

[9]  Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambersten L, Kaltoft M., et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 2010; 50: 329–37.
CrossRef |

[10]  Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in anitmicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010; 16: 402–10.
CrossRef |


   
 
    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2014